RT Journal Article
SR Electronic
T1 The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing ICU capacity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.10.20127084
DO 10.1101/2020.06.10.20127084
A1 Brooke E Nichols
A1 Lise Jamieson
A1 Sabrina RC Zhang
A1 Sheetal Silal
A1 Juliet R.C. Pulliam
A1 Ian Sanne
A1 Gesine Meyer-Rath
YR 2020
UL http://medrxiv.org/content/early/2020/06/12/2020.06.10.20127084.abstract
AB Countries such as South Africa have limited intensive care unit (ICU) capacity to handle the expected number of COVID-19 patients requiring ICU care. Remdesivir can prevent deaths in countries such as South Africa by decreasing the number of days people spend in ICU, therefore freeing up ICU bed capacity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementUSAID funded this work through cooperative agreement 72067419CA00004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors views expressed in this publication do not necessarily reflect the views of USAID or the US Government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data is publicly available; thus, IRB approval was unneeded.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOnly publicly available data were used for this analysis.